German lawmakers approved a comprehensive overhaul of the country’s statutory health-insurance system that forces drug-price reductions on pharmaceutical companies as part of a wider drive to cut billions of euros in costs.
German lawmakers approved a comprehensive overhaul of the country’s statutory health-insurance system that forces drug-price reductions on pharmaceutical companies as part of a wider drive to cut billions of euros in costs.
<iframe src="https://statesidedaily.com/embed/cluster/b152fe010ce3497b8ef9ac33f623ef6c969f2aae" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="German Lawmakers Approve Health Bill Raising Drugmaker Rebates"></iframe>
